These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1655135)

  • 21. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
    Bukh J; Miller RH
    Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of antibody to hepatitis C virus in renal transplant recipients.
    Fernandez JA; Roth D; Burke G; Ranjan D; Esquenazi V; Miller J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):444-5. PubMed ID: 1846716
    [No Abstract]   [Full Text] [Related]  

  • 25. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of C8-2Ag-Ab system for the diagnosis of hepatitis C].
    Mizuno K; Kawahara T; Fujiyama S; Yano M
    Nihon Rinsho; 1991 Feb; 49(2):330-4. PubMed ID: 1707102
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum antibodies to hepatitis C virus: analysis of risk factors of seropositivity in a population of blood donors in metropolitan France].
    Maisonneuve P; Aymard JP; Lemaire JM; Baillet A; Janot C
    Rev Med Interne; 1991; 12(6):416-8. PubMed ID: 1724323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HCV screening of blood donors: the impact in Spain.
    Koff RS
    Gastroenterology; 1991 Mar; 100(3):839-41. PubMed ID: 1847120
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitis.
    Kakaiya R; Stephans J; Carnahan G; Ahmed P; Miller WV
    Transfusion; 1991 Oct; 31(8):780-1. PubMed ID: 1656555
    [No Abstract]   [Full Text] [Related]  

  • 32. [Non-specific reactions of ELISA test for the detection of the hepatitis C virus in blood donors. Immunologic considerations].
    Diallo A; Lazizi Y; Le Guenno B; Pillot J
    Presse Med; 1991 Mar; 20(8):383. PubMed ID: 1826766
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 34. A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood.
    Montebugnoli L; Borea G; Miniero R; Sprovieri G
    Clin Chim Acta; 1999 Oct; 288(1-2):91-6. PubMed ID: 10529461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
    Abb J
    Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
    Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
    Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.